Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1978 Feb;31(2):101–107. doi: 10.1136/jcp.31.2.101

Spectrum of renal tubular damage in renal failure secondary to cirrhosis and fulminant hepatic failure.

S P Wilkinson, D Hirst, D W Day, R Williams
PMCID: PMC1145197  PMID: 632352

Abstract

Measurements of urinary lysozyme were used to evaluate renal tubular integrity in 34 patients with cirrhosis or fulminant hepatic failure who had developed renal impairment. In 18 of the patients the lysozyme values were normal but in the remaining 16 were increased, supporting previous concepts that renal failure complicating hepatocellular disease may occur both without and with tubular necrosis. The lysozyme values were inversely related to the creatinine clearance, suggesting that the development of tubular necrosis may be determined by the level of renal perfusion. The validity of simpler laboratory tests often used to assess renal tubular integrity--namely, the urine sodium concentration, the urine:plasma osmolality ratio, and casts in the urine sediment--was evaluated by comparison with the lysozyme measurements. The urine sodium concentration was of most value and the findings in the sediment were of no value at all.

Full text

PDF
101

Images in this article

104Fig. 3a
on p.104
105Fig. 3
on p.105

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barratt T. M., Crawford R. Lysozyme excretion as a measure of renal tubular dysfunction in children. Clin Sci. 1970 Sep;39(3):457–465. doi: 10.1042/cs0390457. [DOI] [PubMed] [Google Scholar]
  2. Cavanagh D., Rao P. S., Sutton D. M., Bhagat B. D., Bachmann F. Pathophysiology of endotoxin shock in the primate. Am J Obstet Gynecol. 1970 Nov 1;108(5):705–722. doi: 10.1016/0002-9378(70)90535-1. [DOI] [PubMed] [Google Scholar]
  3. Clemente C., Bosch J., Rodés J., Arroyo V., Mas A., Maragall S. Functional renal failure and haemorrhagic gastritis associated with endotoxaemia in cirrhosis. Gut. 1977 Jul;18(7):556–560. doi: 10.1136/gut.18.7.556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Eknoyan G. Letter: Renal disorders in hepatic failure. Br Med J. 1974 Jun 22;2(5920):670–670. doi: 10.1136/bmj.2.5920.670-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. FINCKH E. S., JEREMY D., WHYTE H. M. Structural renal damage and its relatin to clinical features in acute oliguric renal failure. Q J Med. 1962 Oct;31:429–446. [PubMed] [Google Scholar]
  6. Farr M., Wardle E. N., Wilkinson K. Lysozymuria in diabetes. Br Med J. 1976 Mar 13;1(6010):624–625. doi: 10.1136/bmj.1.6010.624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. GILLENWATER J. Y., DOOLEY E. S., FROHLICH E. D. EFFECTS OF ENDOTOXIN ON RENAL FUNCTION AND HEMODYNAMICS. Am J Physiol. 1963 Aug;205:293–297. doi: 10.1152/ajplegacy.1963.205.2.293. [DOI] [PubMed] [Google Scholar]
  8. HECKER R., SHERLOCK S. Electrolyte and circulatory changes in terminal liver failure. Lancet. 1956 Dec 1;271(6953):1121–1125. doi: 10.1016/s0140-6736(56)90149-0. [DOI] [PubMed] [Google Scholar]
  9. Harrison J. F., Parker R. W., De Silva K. L. Lysozymuria and acute disorders of renal function. J Clin Pathol. 1973 Apr;26(4):278–284. doi: 10.1136/jcp.26.4.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hayslett J. P., Perillie P. E., Finch S. C. Urinary muramidase and renal disease. Correlation with renal histology and implication for the mechanism of enzymuria. N Engl J Med. 1968 Sep 5;279(10):506–512. doi: 10.1056/NEJM196809052791002. [DOI] [PubMed] [Google Scholar]
  11. KAZANTZIS G., FLYNN F. V., SPOWAGE J. S., TROTT D. G. Renal tubular malfunction and pulmonary emphysema in cadmium pigment workers. Q J Med. 1963 Apr;32:165–192. [PubMed] [Google Scholar]
  12. LITWACK G. Photometric determination of lysozyme activity. Proc Soc Exp Biol Med. 1955 Jul;89(3):401–403. doi: 10.3181/00379727-89-21824. [DOI] [PubMed] [Google Scholar]
  13. Liehr H., Grün M., Brunswig D., Sautter T. Endotoxinämie bei Leberzirrhose. Z Gastroenterol. 1976 Jan;14(1):14–23. [PubMed] [Google Scholar]
  14. PROCKOP D. J., DAVIDSON W. D. A STUDY OF URINARY AND SERUM LYSOZYME IN PATIENTS WITH RENAL DISEASE. N Engl J Med. 1964 Feb 6;270:269–274. doi: 10.1056/NEJM196402062700602. [DOI] [PubMed] [Google Scholar]
  15. SHEAR L., KLEINERMAN J., GABUZDA G. J. RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. I. CLINICAL AND PATHOLOGIC CHARACTERISTICS. Am J Med. 1965 Aug;39:184–198. doi: 10.1016/0002-9343(65)90041-0. [DOI] [PubMed] [Google Scholar]
  16. Wiernik P. H., Serpick A. A. Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies. Am J Med. 1969 Mar;46(3):330–343. doi: 10.1016/0002-9343(69)90036-9. [DOI] [PubMed] [Google Scholar]
  17. Wilkinson S. P., Arroyo V., Gazzard B. G., Moodie H., Williams R. Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure. Lancet. 1974 Mar 30;1(7857):521–524. doi: 10.1016/s0140-6736(74)92711-1. [DOI] [PubMed] [Google Scholar]
  18. Wilkinson S. P., Blendis L. M., Williams R. Frequency and type of renal and electrolyte disorders in fulminant hepatic failure. Br Med J. 1974 Feb 2;1(5900):186–189. doi: 10.1136/bmj.1.5900.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wilkinson S. P., Moodie H., Stamatakis J. D., Kakkar V. V., Williams R. Endotoxaemia and renal failure in cirrhosis and obstructive jaundice. Br Med J. 1976 Dec 11;2(6049):1415–1418. doi: 10.1136/bmj.2.6049.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES